Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 5

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 5
---
 concerning our industry, our business, and the markets for our product candidates, as well
as data regarding market research, estimates and forecasts prepared by our management. Information that is based on estimates, forecasts,
projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ
materially from events and circumstances reflected in this information. These statements are based upon information available to us as
of the date hereof, and while we believe such information forms a reasonable basis for such statements, such information may be limited
or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all
potentially available relevant information.

You should carefully read this prospectus supplement,
the accompanying base prospectus, the documents that we incorporate by reference herein and therein, and the documents we reference in
this prospectus supplement and the accompanying base prospectus and have filed as exhibits to the registration statement, of which this
prospectus supplement is a part, completely and with the understanding that our actual future results may be materially different from
what we expect. We qualify all of the forward-looking statements in this prospectus supplement and the accompanying base prospectus by
these cautionary statements.

Except as required by law, we assume no obligation
to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated
in any forward-looking statements, whether as a result of new information, future events or otherwise.

<div align='center'>S-4

PROSPECTUS SUPPLEMENT SUMMARY</div>

This summary highlights certain information appearing elsewhere or incorporated by reference in this prospectus supplement, the accompanying base prospectus and the documents incorporated by reference herein and therein. Because it is only a summary, it does not contain all of the information that you should consider before investing in the shares offered hereby and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing elsewhere or incorporated by reference in this prospectus supplement and the accompanying base prospectus. This summary contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions, or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements. See “Special Note Regarding Forward-Looking Statements” before you decide to invest in our common stock